| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1996;94:1655-1664.)
© 1996 American Heart Association, Inc.
Articles |
Adventitial Myofibroblasts Contribute to Neointimal Formation in Injured Porcine Coronary Arteries
the Departments of Medicine (Cardiology) and Surgery (Cardiothoracic Surgery) (J.E.O'B., J.D.M.), Thomas Jefferson University, Philadelphia, Pa.
Correspondence to Andrew Zalewski, MD, Cardiovascular Research Center, Division of Cardiology, Thomas Jefferson University, Suite 410N, 1025 Walnut St, Philadelphia, PA 19107.
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background The adventitia undergoes remodeling changes after a deep medial coronary injury. Because this process is associated with the formation of adventitial myofibroblasts, which resemble medial smooth muscle (SM) cells, we have examined myofibroblast involvement in the development of neointima.
Methods and Results In a porcine model, severe endoluminal coronary injury resulted in fibroblast proliferation and adventitial remodeling. Significant adventitial responses were associated with increased neointimal formation (P<.01). To examine the contribution of adventitial cells to the development of neointima, proliferating cells were labeled with bromodeoxyuridine (BrdU) at 12 and 24 hours after injury, and their subsequent localization was determined by immunohistochemistry (n=24). At 2 to 3 days after severe injury, the adventitia contained numerous BrdU-labeled cells (37±4%), whereas the media demonstrated infrequent labeled cells (4±1%). Adventitial cells lacked 
-SM actin and desmin, which distinguished them from medial SM cells. At 7 to 8 days, some labeled cells acquired characteristics of myofibroblasts expressing -SM actin. They were found to translocate to the gap between dissected media and contributed to the formation of neointima (76±19%). At 18 to 35 days, labeled cells were abundant in the neointima (86±5%). They showed uniform immunostaining for -SM actin but not for desmin, thereby differing from medial SM cells and blood-borne cells.
Conclusions This study demonstrates translocation of adventitial fibroblasts to neointima, their phenotypic modulation to myofibroblasts, and distinct characteristics of myofibroblasts within neointima after severe endoluminal coronary injury. These findings suggest the significance of vascular fibroblasts in the process of arterial repair.
Key Words: adventitia • myofibroblasts • remodeling • restenosis
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The formation of neointima represents a major mechanism of vascular repair.1 Although this process differs in various pathological conditions, proliferation and migration of medial SM cells are thought to play a fundamental role in early stages of intimal thickening.2 3 In particular, numerous experimental studies after acute medial injury have repeatedly identified SM-like cells in different vascular beds during neointimal formation.4 5 6 The development of neointima also has been observed after several adventitial manipulations, which raises the possibility of alternative mechanisms of vascular repair.7 8 9 10 Our recent findings have shown that endoluminal coronary injury results in a significant remodeling of the adventitia, accompanied by the differentiation of adventitial fibroblasts to myofibroblasts, which acquire
-SM actin.11 The presence of myofibroblasts has been a well-recognized hallmark of tissue contraction in various pathological conditions,12 13 14 and it may represent a putative mechanism of unfavorable geometric remodeling manifested by vascular constriction after balloon angioplasty.15 16 17 18
Striking similarities between myofibroblasts and SM cells in regard to their ultrastructural characteristics and the expression of cytoskeletal protein markers (eg, -SM actin) have made distinction between these cell lines particularly difficult.19 These observations have raised the possibility that vascular myofibroblasts not only contribute to the changes affecting the adventitia11 but also may migrate toward the lumen, contributing to neointimal formation. In this study, we have demonstrated migration of adventitial cells to neointima and confirmed their transition to myofibroblasts in porcine coronary arteries after balloon injury. Myofibroblasts in neointima have shown distinct characteristics in regard to the expression of cytoskeletal proteins compared with those cells that remained in the adventitia. These findings demonstrate a new mechanism of vascular repair after a deep medial injury.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Animal Model
Domestic crossbred pigs (Sus scrofa) weighing 23 to 31 kg were premedicated with aspirin (650 mg PO), atropine (1 mg IM), and nifedipine (10 mg sublingual). The pigs were sedated with intramuscular injection of ketamine (20 mg/kg) and xylazine (4 mg/kg). After endotracheal intubation, they were ventilated with isoflurane (1.75%) and oxygen to maintain anesthesia throughout the experiment. The right common carotid artery was surgically exposed, and heparin (10 000 U) was administered intra-arterially. The coronary ostia were cannulated under fluoroscopic guidance with an 8F SAL 1 guiding catheter, and nitroglycerin was administered (100 µg IC). The coronary arteries were injured with an oversized balloon (3.5 to 4.0 mm) inflated three times (6 to 10 atm) for 30 seconds (n=36), whereas noninstrumented coronary arteries served as controls (n=5). The site of balloon inflation was selected according to luminal dimensions of target coronary arteries that corresponded to their comparable microscopic characteristics (muscular arteries). Postsurgical therapy included aspirin 325 mg PO and ampicillin 250 mg IM for the next 2 days. The pigs were euthanatized with intravenous overdose of Euthasol (Delmarva Laboratory) containing pentobarbital sodium (1950 mg) and phenytoin sodium (250 mg) at times indicated in the text. All experiments conformed to the position of the American Heart Association on research animal use and were in accordance with institutional guidelines.
Tissue Processing and Vascular Injury Scoring
To trace migration of proliferating cells, some animals received BrdU (Boehringer Mannheim) at 12 (30 mg/kg IM) and 24 hours (30 mg/kg IV) after the procedure. They were killed at various time points, ranging from 2 to 35 days after balloon injury, as indicated in the text. The entire epicardial porcine coronary arteries and adjacent tissues were removed in a block, rinsed with PBS, and then immersed in HistoChoice tissue fixative (Amresco) for >5 hours. The tissues were sectioned into 
3-mm blocks and processed in a Tissue-Tek VIP processor (Miles Inc). Then they were embedded in paraffin and cut into 5-µm-thick sections. Sections were adhered to glass slides previously coated with Vectabond (Vector Laboratories).
To determine the location and the extent of medial injury, the tissue sections were deparaffinized, and Verhoeff's stain for elastic tissues20 was used in the representative slides from each block. Severe injury was defined as the disruption of the media resulting in the exposure of the adventitia to the lumen. Mild injury was defined as punctated breaks in the IEL and/or incomplete medial damage without direct exposure of the adventitia to the lumen (Fig 1
). Three independent observers graded the severity of arterial injury. The number of vessels examined for each parameter is reported as the n value in the "Results" section.
|
Immunohistochemistry
The Vectastain Elite ABC system (Vector Laboratories) was used for immunohistochemistry. At least 10 sections from each coronary artery with defined degree of injury (mild or severe) were analyzed. Sections were deparaffinized, incubated with 0.6% hydrogen peroxide in methanol for 30 minutes, and blocked with 5% horse serum when mouse monoclonal antibody was used. For BrdU staining, sections were treated with 2 N HCl at 37°C for 30 minutes after blocking and then incubated with 0.1 mol/L Borax (Sigma Diagnostics) for 10 minutes. After being washed in PBS, sections were incubated with primary antibodies for 1 hour at room temperature in a moisture chamber. The following primary antibodies were used: monoclonal mouse 1A4 antibody recognizing -SM actin (1:100, Sigma Diagnostics), monoclonal mouse DE-R-11 antibody recognizing intermediate filament desmin (1:50, Novocastra), and monoclonal mouse antibody recognizing BrdU (1:200, Novocastra). Afterward, slides were washed and incubated with biotinylated secondary horse anti-mouse antibodies (1:2000, Vector Laboratories) for 1 hour. They were visualized with DAB substrate (Vector Laboratories) followed by counterstain with Gill's hematoxylin (Sigma Diagnostics). Negative controls were carried out with nonimmune serum instead of primary antibody.
For double immunohistochemistry, sections were stained first with primary antibodies against BrdU as described above. After incubation with DAB substrate, they were washed in PBS three times and blocked with 5% horse serum. Afterward, slides were incubated with the second primary antibodies (against -SM actin or desmin) that were visualized with VIP substrate (Vector Laboratories).
Quantitative Measurements
From each coronary artery, at least three sections from different tissue blocks (3 to 5 mm apart) demonstrating only severe or mild injury were subjected to quantitative analyses. The percentage of BrdU-positive cells (dark-brown nuclear stain) was calculated in the vicinity of injury and on the opposite side for the adventitia and media. Likewise, BrdU-labeled cells were counted in neointima. In each compartment, 
500 cells were counted by use of the same objective magnification, and then mean values for multiple sections were calculated to minimize selection bias. In sections stained with Verhoeff's, neointimal and adventitial areas were measured with computerized planimetry. In vessels with severe injury, neointimal areas were delineated by the inner edge of the EEL, the border of dissected media, and the luminal edge of the neointima. In vessels with mild injury, neointimal areas were traced between the IEL, media, and luminal edge of the neointima. Adventitial areas were defined between the inner border of the EEL outward to the edge of the adipose tissue or myocardium. Repeated measurements yielded an intraobserver variability of <10%.
Statistical Analysis
All numerical data are presented as mean±SEM. One-way ANOVA was used to compare the multigroup variables. If the F test results were significant, Bonferroni's analysis was carried out to determine differences among subgroups. A value of P<.05 was required to reject the null hypothesis.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Adventitial Injury and Vascular Repair
To assess the vascular response to injury, proliferating cells within the adventitia, morphometric changes affecting the outer layer of the vessel, and the ensuing neointimal formation were quantified in porcine coronary arteries. As expected, a comparable balloon overstretch resulted in variable vascular damage (Fig 1
). Accordingly, the comparisons were carried out between the groups with severe injury (ie, medial disruption exposing the adventitia to the lumen) and mild injury (ie, medial injury resulting in no direct contact of the adventitia with the lumen). As the Table shows, severe injury (n=23) was associated with significant cell proliferation within the adventitia (at 2 to 3 days) and adventitial remodeling (at 7 to 8 days), followed by increased neointimal formation (at 18 to 35 days). In contrast, mild injury (n=13) produced markedly attenuated adventitial changes and significantly smaller neointima (Fig 1). The above relationship between adventitial changes and the ensuing neointimal formation raised the possibility of the contribution of adventitial cells in vascular repair of a severely injured artery.
|
Translocation of Adventitial Cells
To examine whether translocation of adventitial cells contributes to the development of neointima after severe coronary arterial injury, BrdU was administered at 12 and 24 hours after the procedure, and the subsequent localization of labeled cells was analyzed. At 2 days after severe injury (n=6), medial dissection at the site of injury and a variable amount of thrombus constituted typical microscopic features (Fig 2A). As Fig 2B through 2D shows, most BrdU-labeled cells were circumferentially distributed in the adventitia (37±4% of adventitial cells), which contrasted with their small number in the media (4±1% of medial cells, P<.001).
|
At 7 to 8 days (n=4), focal adventitial thickening and a thin layer of the neointima interdigitated with residual thrombus were seen at the site of medial injury (Fig 3A). As Fig 3B through 3D shows, the cells labeled with BrdU during the first 24 hours accumulated on both sides of the EEL, with some demonstrating distorted morphology while migrating through the EEL. Numerous neointimal cells contained the label (76±19%). At 18 to 35 days (n=5), persistent thickening of the adventitia and a well-developed neointima surrounding the retracted media were present (Fig 4A). Most neointimal cells exhibited the presence of the BrdU (86±5%) with staining of a variable intensity, suggesting a gradual loss of the label after multiple cell replications (Fig 4B through 4D).
|
|
In vessels exhibiting mild injury, the absence of adventitial activation was associated with rare BrdU-labeled cells (<5%) in the media at all time points. Likewise, small areas of neointima at 18 to 35 days (n=4) contained infrequent labeled cells (30±14%, P<.005 versus severe injury). Thus, the media appeared to function as a protective barrier, preventing adventitial cell activation and their subsequent migration, which resulted in attenuated neointimal formation.
Characteristics of Translocating Cells
To characterize the cells that translocated from the adventitia to neointima during vascular repair, we have determined their phenotype by assessing cytoskeletal protein markers. At 2 days after injury, the adventitia was composed of fibroblasts and blood-borne cells that differed from medial SM cells lacking -SM actin and desmin immunostaining. In the media, the majority of BrdU-labeled cells were also devoid of -SM actin, suggesting their nonmuscle origin (Fig 5A and 5B).
|
At 7 to 8 days, the adventitia showed areas of focal immunoreactivity with -SM actin antibodies, indicating fibroblast differentiation to myofibroblasts. Double immunohistochemistry has shown that 28% of BrdU-labeled cells in the adventitia and 96% of BrdU-labeled cells in the neointima colocalized -SM actin (Fig 5C and 5D). To exclude that the latter represented inadvertently labeled medial SM cells that then migrated to neointima, in separate experiments (n=3) BrdU administration was delayed for 72 hours after injury, again demonstrating infrequent medial cell proliferation in only 5.3±2% of cells.
At 35 days, neointimal cells continued to exhibit uniform -SM actin immunostaining. In contrast to medial SM cells, the immunoreactivity with desmin antibodies was patchy in neointima (Fig 6). Double immunohistochemistry for BrdU and -SM actin or desmin demonstrated that most cells that translocated from the adventitia to neointima showed -SM actin but not desmin immunostaining (Fig 6). Accordingly, neointimal myofibroblasts exhibited a distinctive repertoire of cytoskeletal protein markers (-SM actin positive and desmin negative), distinguishing them from medial SM cells (both -SM actin and desmin positive), nonmigratory adventitial cells, and blood-borne inflammatory cells (both -SM actin and desmin negative).
|
Characteristics of Nontranslocating cells
Notwithstanding the process of translocation of myofibroblasts to neointima, a number of BrdU-labeled cells remained in the adventitia. At 18 to 35 days after injury, these cells were found in the periphery of the adventitia and in the vicinity of the vasa vasorum. They were devoid of both -SM actin and desmin. Their localization and morphological features (ie, round shape, large nucleus, and small cytoplasm) were consistent with blood-borne inflammatory cells that probably were recruited into the injured adventitia.
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
We have previously shown the induction of adventitial fibroblast proliferation and the modulation of their phenotype to myofibroblasts after arterial injury.11 The present study demonstrated direct involvement of adventitial fibroblasts in neointimal formation after severe endoluminal injury in porcine coronary arteries. The activation of adventitial cells and their migration to the luminal surface of the injured vessels appeared critical for the ensuing neointimal formation. Myofibroblasts residing in different layers of the arterial wall exhibited distinct characteristics during the vascular repair process.
Activation of Adventitial Cells
Balloon-induced injury of the coronary arteries caused a spectrum of vascular responses. Activation of the adventitia, which included cell proliferation and adventitial remodeling, was present in the arteries with severe injury and was limited to the sites where the adventitia was exposed to the vessel lumen as a result of medial disruption. Importantly, adventitial changes were associated with the subsequent formation of neointima. In contrast, when the adventitia was protected by the injured but not disrupted media, adventitial activation and the development of neointima were markedly attenuated (see the Table). These observations suggest a causal relationship between the exposure of the adventitia to the vessel lumen, fibroblast activation/migration, and the subsequent neointimal formation.
Unlike the involvement of medial SM cells, activation of the adventitia has not previously been characterized during vascular response to injury. Hence, the question of whether adventitial changes represent a common mechanism involved in vascular repair or are merely a model-dependent phenomenon arises. Several lines of evidence suggest ubiquitous involvement of adventitial cells in the vascular repair process. First, because of frequent removal of the adventitia during vessel processing or the quantification of cell replication only within the media and neointima, adventitial proliferation was likely overlooked in prior studies.4 5 If the adventitia is omitted from the analysis in porcine coronary arteries, the time course of medial and neointimal proliferation is similar to that described for a well-characterized rat injury model. Second, balloon denudation of rabbit femoral arteries results in activation of the adventitia (Y.S., A.Z., unpublished results). Hence, the subsequent neointimal thickening in this model could result from not only balloon-induced medial cell migration but also concomitant activation of the adventitia and the subsequent translocation of adventitial cells. Third, the injury involving the outer layer of the vessel is critical for neointimal development. Selective adventitial injury even without endothelial denudation is associated with the formation of neointima.10 Likewise, the removal of the entire media has recently been reported to be accompanied by significant neointimal formation.21
Involvement of Myofibroblasts in Neointimal Formation
We have used the in vivo BrdU labeling method to trace migration of adventitial cells toward the lumen and their involvement in neointimal formation. A rapid clearance of BrdU from the circulation allowed us to label cells in the S phase during a narrow time window.22 23 Hence, the ensuing changes in the localization of labeled cells reflected their migration as opposed to ongoing proliferation.24 25
Blood-borne inflammatory cells (eg, macrophages), SM cells, and vascular fibroblasts should be considered potential components of the BrdU-labeled cell population. The presence of BrdU-positive cells in the vicinity of the vasa vasorum and the exposure of the adventitia to blood elements after severe injury clearly suggest some infiltration of the injured adventitia with macrophages. They likely contributed to the formation of myofibroblasts through their secreted products, as previously described in wound healing.26 27 The infiltration of adventitia with blood-borne cells notwithstanding, the acquisition of -SM actin by some labeled cells in the adventitia at 7 to 8 days indicated that proliferating fibroblasts constituted an important cellular element during the adventitial response to coronary injury.
Although cells translocating to the neointima showed certain similarities with medial SM cells (eg, -SM actin expression), several differences underscored their separate origins. Activated adventitial cells did not express -SM actin or desmin at 2 days after injury, whereas SM cells present in adventitial vasa vasorum and in the injured media were strongly positive for both cytoskeletal protein markers at all times. Migration of SM cells to the adventitia also was unlikely because the translocation of BrdU-labeled cells indicated cell migration in the opposite direction. It is important to emphasize that the results of this study did not preclude migration of medial cells to neointima. The media of normal arteries contains a small number of "nonmuscle" cells.28 29 In fact, after injury most labeled cells in the media lacked -SM actin, which likely identified them as medial fibroblasts (Fig 5A). Recent findings indicate that these cells closely resemble adventitial fibroblasts in regard to morphology, cytoskeletal proteins, and a high growth potential, whereas medial SM cells appear unable to undergo the phenotypic changes required for neointimal formation.30 Hence, in severe medial injury, both adventitial and medial fibroblasts could contribute to neointimal formation. After milder coronary injury, however, the origin of a small neointima remains to be further clarified.
The mechanisms regulating fibroblast migration to neointima are unknown. Adventitial fibroblasts and myofibroblasts translocated toward medial dissections, which is consistent with the chemotactant gradient of locally released platelet-derived growth factor and transforming growth factor ß1.31 32 33 Intraluminal thrombus, which contains the above-mentioned cytokines, was a typical feature of severe coronary injury. It can also be postulated that migrating cells produce extracellular matrix-degrading enzymes and plasminogen activators that facilitate their movement,34 35 which parallels a similar ability of fibroblasts to degrade connective tissue in other reparative processes after tissue damage.36
Neointimal Myofibroblasts
Myofibroblasts residing in different compartments of the vascular wall exhibited distinct characteristics. Similar to myofibroblasts in wound healing, adventitial myofibroblasts were markedly reduced at later times after vascular injury.11 13 14 This may reflect their migration to neointima, the removal by apoptosis, or the reversal to an undifferentiated fibroblast phenotype. In contrast, migratory myofibroblasts that reached the neointima have shown a sustained -SM actin expression resembling the prolonged presence of myofibroblasts in hypertrophic scars and other pathological conditions.37 38 39 Although neointimal cells uniformly expressed -SM actin, most cells of adventitial origin (ie, BrdU-labeled) were negative for desmin at 35 days after injury. This pattern of desmin immunostaining in the neointima has previously been interpreted as evidence that medial SM cells lose their intermediate filaments after vascular injury.40 41 42 Alternatively, our findings not only suggest distinctive signaling mechanisms within the neointima but also may reflect characteristics of unique cellular components such as myofibroblasts. It is noteworthy that a similar nonuniform distribution of desmin has been observed during reparative processes involving myofibroblasts in nonvascular tissues.43
Study Limitations
The demonstrated myofibroblast migration from the adventitia to neointima was based on the tracing BrdU-labeled cells that acquired -SM actin after severe coronary injury. Regional differences in vascular responses to endoluminal injury or the variation in fibroblast content in various vascular beds (eg, coronary versus peripheral circulation) may modify the proposed mechanism of arterial repair. The development of newer cellular markers specific for fibroblasts or myofibroblasts, which distinguish them from surrounding SM cells, may facilitate future studies.44 It is important to underscore that the migration of adventitial cells to the neointima was likely underestimated for several reasons. First, we have selected a very early time point for the BrdU administration to avoid labeling of cells that have either migrated to the media or originated from the media. This excluded those adventitial cells that entered the cell cycle later and then migrated to the neointima. Second, neointimal cells of adventitial origin exhibited decreasing intensity of the BrdU staining, probably as a result of ongoing cell divisions, resulting in the loss of the label in some cells. Finally, because cell migration also involves nonreplicating cells,45 the BrdU method could not identify all adventitial cells involved in this process.
The findings of this study describe adventitial involvement in the vessel repair process after injury to nonatherosclerotic coronary arteries. It should be underscored that vascular responses are more complex in diseased vessels, with the underlying intima and diverse components of atherosclerotic plaque. Severe vascular injury exposing the adventitia, however, is expected to occur after several transcatheter coronary interventions, including a high-pressure stent implantation, an atherectomy, or a coronary angioplasty.46 47 48 Nevertheless, the exact role of myofibroblasts in geometric remodeling and neointimal formation remains to be determined in clinical settings.
Conclusions
Vascular injury induces proliferation and migration of adventitial fibroblasts, accompanied by their phenotypic modulation to myofibroblasts. The translocation of adventitial myofibroblasts across the EEL toward the lumen after severe medial injury brings into question the sole contribution of SM cells to neointimal formation. These data suggest the significance of myofibroblasts in vascular repair and illustrate a new mechanism whereby adventitial fibroblasts may contribute to restenosis after angioplasty.
|
Selected Abbreviations and Acronyms |
|---|
|
|
Acknowledgments |
|---|
This study was supported in part by NIH grant HL-55410 and a standard grant-in-aid from the American Heart Association, Florida and Delaware Affiliates, Inc. Dr Fard was supported by a fellowship grant from the American Heart Association, Delaware Affiliate, Inc. We gratefully acknowledge the technical assistance of Felicia Hayes.
|
Footnotes |
|---|
Presented in part at the 68th Scientific Sessions of the American Heart Association, Anaheim, Calif, November 13-16, 1995, and previously published in abstract form (Circulation. 1995;92[suppl I]:I-34).
Received December 28, 1995; revision received April 1, 1996; accepted April 15, 1996.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Schwartz SM, deBlois D, O'Brien ERM. The intima: soil for atherosclerosis and restenosis. Circ Res. 1995;77:445-465.
2. Ross R, Wight TN, Strandness E, Thiele B. Human atherosclerosis, I: cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol. 1984;114:79-93.[Abstract]
3. Austin GE, Ratliff NB, Hollman J, Tabei S, Phillips DF. Intimal proliferation of smooth muscle as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1985;6:369-375.[Abstract]
4. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.[Medline] [Order article via Infotrieve]
5.
Hanke H, Strohchneider T, Oberhoff M, Betz E, Karsch KR. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ Res. 1990;67:651-659.
6.
Schwartz RS, Murphy JG, Edwards WD, Camrud AR, Vliestra RE, Holmes DR. Restenosis after balloon angioplasty: a practical proliferative model in porcine coronary arteries. Circulation. 1990;82:2190-2200.
7. Webster WS, Bishop SP, Geer JC. Experimental aortic intimal thickening. Am J Pathol. 1974;76:245-264.[Medline] [Order article via Infotrieve]
8. Booth RFG, Martin JF, Honey AC, Hassall DG, Beesley JE, Moncada S. Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. Atherosclerosis. 1989;76:257-268.[Medline] [Order article via Infotrieve]
9. Prescott MF, McBride CK, Court M. Development of intimal lesions after leukocyte migration into the vascular wall. Am J Pathol. 1989;135:835-846.[Abstract]
10. Beesley JE, Honey AC, Martin JF. Ultrastructural assessment of lesion development in the collared rabbit carotid artery model. Cells and Materials. 1992;2:201-208.
11.
Shi Y, Pieniek M, Fard A, O'Brien J, Mannion JD, Zalewski A. Adventitial remodeling following coronary arterial injury. Circulation. 1996;93:340-348.
12.
Arora PD, McCulloch CAG. Dependence of collagen remodelling on -smooth muscle actin expression by fibroblasts. J Cell Physiol. 1994;159:161-175.[Medline]
[Order article via Infotrieve]
13.
Darby I, Skalli O, Gabbiani G. -Smooth muscle actin is transiently expressed in by myofibroblasts during experimental wound healing. Lab Invest. 1990;63:21-29.[Medline]
[Order article via Infotrieve]
14.
Welch MP, Odland GF, Clark RAF. Temporal relationship of F-actin bundle formation, collagen and fibronectin matrix assembly, fibronectin receptor expression to wound contraction. J Cell Biol. 1990;110:133-145.
15.
Post MJ, Borst C, Kuntz RE. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. Circulation. 1994;89:2816-2821.
16.
Kakuta T, Currier JW, Haudenschild CC, Ryan TJ, Faxon DP. Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation. 1994;89:2809-2815.
17.
Lafont A, Guzman LA, Whitlow PL, Goormastic M, Cornhill JF, Chisolm GM. Restenosis after experimental angioplasty: intimal, medial, and adventitial changes associated with constrictive remodeling. Circ Res. 1995;76:996-1001.
18. Mintz GS, Kovach JA, Pichard AD, Kent KM, Satler LF, Popma JJ, Painter JA, Morgan K, Leon MB. Geometric remodelling is the predominant mechanism of clinical restenosis after coronary angioplasty. J Am Coll Cardiol. 1994;23:138A. Abstract.
19.
Desmouliere A, Rubbia-Brandt L, Abdiu A, Walz T, Macieira-Coelho A, Gabbiani G. -Smooth muscle actin is expressed in a subpopulation of cultured and cloned fibroblasts and is modulated by 
-interferon. Exp Cell Res. 1992;201:64-73.[Medline]
[Order article via Infotrieve]
20. McElroy DA. Connective tissue. In: Prophet EB, Mills B, Arrington JB, Sobin LH, eds. Laboratory Methods in Histotechnology. Washington, DC: American Registry of Pathology; 1992:132-135.
21.
Andersen HR, Mæng M, Thorwest M, Falk E. Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury: insights from a porcine coronary (re)stenosis model. Circulation. 1996;93:1716-1724.
22. Dean PN, Dolbeare F, Gratzner H, Rice GC, Gray JW. Cell-cycle analysis using a monoclonal antibody to BrdUrd. Cell Tissue Kinet. 1984;17:427-436.[Medline] [Order article via Infotrieve]
23. Kriss JP, Revesz L. The distribution and fate of bromodeoxyuridine and bromodeoxycytidine in the mouse and rat. Cancer Res. 1962;22:254-265.
24. Wynford-Thomas D, Williams ED. Use of bromodeoxyuridine for cell kinetics studies in intact animals. Cell Tissue Kinet. 1986;19:179-182.[Medline] [Order article via Infotrieve]
25. Bicknell S, van Eeden S, Hayashi S, Hards J, English D, Hogg JC. A non-radioisotopic method for tracing neutrophils in vivo using 5'-bromo-2'-deoxyuridine. Am J Respir Cell Mol Biol. 1994;10:16-23.[Abstract]
26. Vyalov S, Desmouliere A, Gabbiani G. GM-CSF-induced granulation tissue formation: relationship between macrophage and myofibroblast accumulation. Virchows Archiv B Cell Pathol. 1993;63:231-239.
27.
Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-ß1 induces -smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growinq cultured fibroblasts. J Cell Biol. 1993;122:103-111.
28. Skalli O, Bloom WS, Ropraz P, Azzarone B, Gabbiani G. Cytoskeletal remodeling of rat aortic smooth muscle cells in vitro: relationships to culture conditions and analogies to in vivo situations. J Submicrosc Cytol Pathol. 1986;18:481-493.
29.
Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against -smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol. 1986;103:2787-2796.
30. Holifield B, Helgason T, Jemelka S, Taylor A, Navran S, Allen J, Seidel C. Differentiated vascular myocytes: are they involved in neointimal formation? J Clin Invest. 1996;97:814-825.[Medline] [Order article via Infotrieve]
31. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest. 1992;89:507-511.
32.
Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor ß. J Exp Med. 1987;165:251-256.
33. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA. Production of transforming growth factor ß1 during repair of arterial injury J Clin Invest. 1991;88:904-910.
34.
Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res. 1994;75:539-545.
35.
Clowes AW, Clowes MM, Au YPT, Reidy MA, Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res. 1990;67:61-67.
36. Murphy G, Docherty AJP, Hembry RM, Reynolds JJ. Metalloproteinases and tissue damage. Br J Rheumatol. 1991;30(suppl):25-31.
37. Hogemann B, Gillessen A, Bocker W, Rauterberg J, Domschke W. Myofibroblast-like cells produce mRNA for type I and III procollagens in chronic active hepatitis. Scand J Gastroenterol. 1993;28:591-594.[Medline] [Order article via Infotrieve]
38. Schmitt-Graff A, Desmouliere A, Gabbiani G. Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Arch. 1994;425:3-24.[Medline] [Order article via Infotrieve]
39. Zhang K, Rekhter MD, Gordon D, Phan SH. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. Am J Pathol. 1994;145:114-125.[Abstract]
40. Kocher O, Skalli O, Bloom WS, Gabbiani G. Cytoskeleton of rat aortic smooth muscle cells. Lab Invest. 1984;50:645-652.[Medline] [Order article via Infotrieve]
41. Kocher O, Gabbiani G. Cytoskeletal features of normal and atheromatous human arterial smooth muscle cells. Hum Pathol. 1984;17:875-880.
42. Takase S, Leo MA, Nouchi T, Lieber CS. Desmin distinguishes cultured fat-storing cells from myofibroblasts, smooth muscle cells and fibroblasts in the rat. J Hepatol. 1988;6:267-276.[Medline] [Order article via Infotrieve]
43. Skalli O, Schurch W, Seemayer T, Lagace R, Monton D, Pittet B, Gabbiani G. Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest. 1989;60:275-285.[Medline] [Order article via Infotrieve]
44.
Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, Neilson EG. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol. 1995;130:393-405.
45.
Clowes AW, Schwartz SM. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res. 1985;56:139-145.
46. Kohchi K, Takebayashi S, Block PC, Hiroki T, Nobuyoshi M. Arterial changes after percutaneous coronary angioplasty: results at autopsy. J Am Coll Cardiol. 1987;10:592-599.[Abstract]
47. den Heijer P, Foley DP, Escaned J, Hillege HL, van Dijk RB, Serruys PW, Lie KI. Angioscopic versus angiographic detection of intimal dissection and intracoronary thrombus. J Am Coll Cardiol. 1994;24:649-654.[Abstract]
48.
Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis JM. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995;91:1676-1688.
This article has been cited by other articles:
 |
|
 |
|
  B. S. Fleenor and D. K. Bowles Negligible contribution of coronary adventitial fibroblasts to neointimal formation following balloon angioplasty in swine Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1532 - H1539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Roy-Chaudhury, Y. Wang, M. Krishnamoorthy, J. Zhang, R. Banerjee, R. Munda, S. Heffelfinger, and L. Arend Cellular phenotypes in human stenotic lesions from haemodialysis vascular access Nephrol. Dial. Transplant., April 17, 2009; (2009) gfn708v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Yau, P. Molnar, M. C. Moon, S. Buhay, J. P. Werner, K. Molnar, L. Saward, D. Del Rizzo, and P. Zahradka meta-Iodobenzylguanidine, an Inhibitor of Arginine-Dependent Mono(ADP-ribosyl)ation, Prevents Neointimal Hyperplasia J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 717 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-A. Hassantash, B. Bikdeli, S. Kalantarian, M. Sadeghian, and H. Afshar Pathophysiology of Aortocoronary Saphenous Vein Bypass Graft Disease Asian Cardiovasc Thorac Ann, August 1, 2008; 16(4): 331 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Haurani, M. E. Cifuentes, A. D. Shepard, and P. J. Pagano Nox4 Oxidase Overexpression Specifically Decreases Endogenous Nox4 mRNA and Inhibits Angiotensin II-Induced Adventitial Myofibroblast Migration Hypertension, July 1, 2008; 52(1): 143 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. House and H. A. Singer CaMKII-{delta} Isoform Regulation of Neointima Formation After Vascular Injury Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 441 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Romagnoli, G. M. Sangiorgi, J. Cosgrave, E. Guillet, and A. Colombo Drug-eluting stenting the case for post-dilation. J. Am. Coll. Cardiol. Intv., February 1, 2008; 1(1): 22 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Borensztajn, J. Stiekema, S. Nijmeijer, P. H. Reitsma, M. P. Peppelenbosch, and C. A. Spek Factor Xa Stimulates Proinflammatory and Profibrotic Responses in Fibroblasts via Protease-Activated Receptor-2 Activation Am. J. Pathol., February 1, 2008; 172(2): 309 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Diez, J. A. Barbera, E. Ferrer, R. Fernandez-Lloris, S. Pizarro, J. Roca, and V. I. Peinado Plasticity of CD133+ cells: Role in pulmonary vascular remodeling Cardiovasc Res, December 1, 2007; 76(3): 517 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Li, C. M. Terry, D. K. Blumenthal, T. Kuji, T. Masaki, B. C. H. Kwan, I. Zhuplatov, J. K. Leypoldt, and A. K. Cheung Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft model Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3139 - 3146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Maiellaro and W. R. Taylor The role of the adventitia in vascular inflammation Cardiovasc Res, September 1, 2007; 75(4): 640 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C.M. Siow and A. T. Churchman Adventitial growth factor signalling and vascular remodelling: Potential of perivascular gene transfer from the outside-in Cardiovasc Res, September 1, 2007; 75(4): 659 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. Auger, P. D'Orleans-Juste, and L. Germain Adventitia contribution to vascular contraction: Hints provided by tissue-engineered substitutes Cardiovasc Res, September 1, 2007; 75(4): 669 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Haurani and P. J. Pagano Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: Bellwether for vascular disease? Cardiovasc Res, September 1, 2007; 75(4): 679 - 689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. An, R. Boyd, M. Zhu, A. Chapman, D. R. Pimentel, and H. D. Wang NADPH oxidase mediates angiotensin II-induced endothelin-1 expression in vascular adventitial fibroblasts Cardiovasc Res, September 1, 2007; 75(4): 702 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M Kielty, S. Stephan, M. J Sherratt, M. Williamson, and C. A. Shuttleworth Applying elastic fibre biology in vascular tissue engineering Phil Trans R Soc B, August 29, 2007; 362(1484): 1293 - 1312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J.W. Wallitt, M. Jevon, and P. I. Hornick Therapeutics of Vein Graft Intimal Hyperplasia: 100 Years On Ann. Thorac. Surg., July 1, 2007; 84(1): 317 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Garanich, R. A. Mathura, Z.-D. Shi, and J. M. Tarbell Effects of fluid shear stress on adventitial fibroblast migration: implications for flow-mediated mechanisms of arterialization and intimal hyperplasia Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3128 - H3135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-J. Li, H.-W. Sun, F.-L. Zhu, L. Chen, Y.-Y. Rong, Y. Zhang, and M. Zhang Local adiponectin treatment reduces atherosclerotic plaque size in rabbits J. Endocrinol., April 1, 2007; 193(1): 137 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Collison, A. Agarwal, and N. Trehan Controversies in the use of intraluminal shunts during off-pump coronary artery bypass grafting surgery. Ann. Thorac. Surg., October 1, 2006; 82(4): 1559 - 1566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Kelly, M. Melhem, J. Zhang, G. Kasting, J. Li, M. Krishnamoorthy, S. Heffelfinger, S. Rudich, P. Desai, and P. Roy-Chaudhury Perivascular paclitaxel wraps block arteriovenous graft stenosis in a pig model Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2425 - 2431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. Barber, M. Kanagasundaram, C. R. Anderson, L. M. Burrell, and R. L. Woods Vascular neutral endopeptidase inhibition improves endothelial function and reduces intimal hyperplasia Cardiovasc Res, July 1, 2006; 71(1): 179 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Schafer, M. R. Schroeter, C. Dellas, M. Puls, M. Nitsche, E. Weiss, G. Hasenfuss, and S. V. Konstantinides Plasminogen Activator Inhibitor-1 From Bone Marrow-Derived Cells Suppresses Neointimal Formation After Vascular Injury in Mice Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1254 - 1259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Weaver, J. Liu, D. Pimentel, D. J. Reddy, P. Harding, E. L. Peterson, and P. J. Pagano Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1933 - H1941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Stenmark, N. Davie, M. Frid, E. Gerasimovskaya, and M. Das Role of the Adventitia in Pulmonary Vascular Remodeling Physiology, April 1, 2006; 21(2): 134 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Roy-Chaudhury, V. P. Sukhatme, and A. K. Cheung Hemodialysis Vascular Access Dysfunction: A Cellular and Molecular Viewpoint J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1112 - 1127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-N. Zhang, D. W. Wilson, V. da Cunha, M. E. Sullivan, R. Vergona, J. C. Rutledge, and Y.-X. Wang Endothelial NO Synthase Deficiency Promotes Smooth Muscle Progenitor Cells in Association With Upregulation of Stromal Cell-Derived Factor-1{alpha} in a Mouse Model of Carotid Artery Ligation Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 765 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chamberlain, D. Evans, A. King, R. Dewberry, S. Dower, D. Crossman, and S. Francis Interleukin-1{beta} and Signaling of Interleukin-1 in Vascular Wall and Circulating Cells Modulates the Extent of Neointima Formation in Mice Am. J. Pathol., April 1, 2006; 168(4): 1396 - 1403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A K Mitra and D K Agrawal In stent restenosis: bane of the stent era. J. Clin. Pathol., March 1, 2006; 59(3): 232 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. An, R. Boyd, Y. Wang, X. Qiu, and H. D. Wang Endothelin-1 expression in vascular adventitial fibroblasts Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H700 - H708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Alvarez Jr and N. K. Kapur Drug Eluting Stent Technology: A Paradigm Shift in the Treatment and Prevention of Restenosis Journal of Pharmacy Practice, December 1, 2005; 18(6): 461 - 478. [Abstract] [PDF]
|
|
|
|
|
|
G. J. Wang, X. X. Sui, H. F. Simosa, M. K. Jain, D. C. Altieri, and M. S. Conte Regulation of Vein Graft Hyperplasia by Survivin, an Inhibitor of Apoptosis Protein Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2081 - 2087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. A. Ali, C. A. Bursill, Y. Hu, R. P. Choudhury, Q. Xu, D. R. Greaves, and K. M. Channon Gene Transfer of a Broad Spectrum CC-Chemokine Inhibitor Reduces Vein Graft Atherosclerosis in Apolipoprotein E-Knockout Mice Circulation, August 30, 2005; 112(9_suppl): I-235 - I-241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Fogelstrand, K. Osterberg, and E. Mattsson Reduced neointima in vein grafts following a blockage of cell recruitment from the vein and the surrounding tissue Cardiovasc Res, August 1, 2005; 67(2): 326 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hayashida, J. Fujita, Y. Miyake, H. Kawada, K. Ando, S. Ogawa, and K. Fukuda Bone Marrow-Derived Cells Contribute to Pulmonary Vascular Remodeling in Hypoxia-Induced Pulmonary Hypertension Chest, May 1, 2005; 127(5): 1793 - 1798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hayashi, H. Banno, K. Kadomatsu, Y. Takei, K. Komori, and T. Muramatsu Antisense oligodeoxyribonucleotide as to the growth factor midkine suppresses neointima formation induced by balloon injury Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2203 - H2209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yoshida and G. K. Owens Molecular Determinants of Vascular Smooth Muscle Cell Diversity Circ. Res., February 18, 2005; 96(3): 280 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Somoza, M. C. Gonzalez, J. M. Gonzalez, F. Abderrahim, S. M. Arribas, and M. S. Fernandez-Alfonso Modulatory role of the adventitia on noradrenaline and angiotensin II responses: Role of endothelium and AT2 receptors Cardiovasc Res, February 1, 2005; 65(2): 478 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Kahn, K. Boesze-Battaglia, D. W. Stepp, A. Petrov, Y. Huang, R. P. Mason, and T. N. Tulenko Influence of serum cholesterol on atherogenesis and intimal hyperplasia after angioplasty: inhibition by amlodipine Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H591 - H600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Dourron, G. M. Jacobson, J. L. Park, J. Liu, D. J. Reddy, M. L. Scheel, and P. J. Pagano Perivascular gene transfer of NADPH oxidase inhibitor suppresses angioplasty-induced neointimal proliferation of rat carotid artery Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H946 - H953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Chandiwal, V. Balasubramanian, Z. K. Baldwin, M. S. Conte, and L. B. Schwartz Gene Therapy for the Extension of Vein Graft Patency: A Review Vascular and Endovascular Surgery, January 1, 2005; 39(1): 1 - 14. [Abstract] [PDF]
|
|
|
|
 |
|
 A. C. Newby Dual Role of Matrix Metalloproteinases (Matrixins) in Intimal Thickening and Atherosclerotic Plaque Rupture Physiol Rev, January 1, 2005; 85(1): 1 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Perlegas, H. Xie, S. Sinha, A. V. Somlyo, and G. K. Owens ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H96 - H102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. V. Subramanian, J. A. Polikandriotis, R. J. Kelm Jr., J. J. David, C. G. Orosz, and A. R. Strauch Induction of Vascular Smooth Muscle {alpha}-Actin Gene Transcription in Transforming Growth Factor {beta}1-Activated Myofibroblasts Mediated by Dynamic Interplay between the Pur Repressor Proteins and Sp1/Smad Coactivators Mol. Biol. Cell, October 1, 2004; 15(10): 4532 - 4543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. Cooley Murine Model of Neointimal Formation and Stenosis in Vein Grafts Arterioscler. Thromb. Vasc. Biol., July 1, 2004; 24(7): 1180 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Mourani, P. J. Garl, J. M. Wenzlau, T. C. Carpenter, K. R. Stenmark, and M. C.M. Weiser-Evans Unique, Highly Proliferative Growth Phenotype Expressed by Embryonic and Neointimal Smooth Muscle Cells Is Driven by Constitutive Akt, mTOR, and p70S6K Signaling and Is Actively Repressed by PTEN Circulation, March 16, 2004; 109(10): 1299 - 1306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. B. Hangler, K. Pfaller, E. Ruttmann, D. Hoefer, T. Schachner, G. Laufer, and H. Antretter Effects of intracoronary shunts on coronary endothelial coating in the human beating heart Ann. Thorac. Surg., March 1, 2004; 77(3): 776 - 780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, N. J. Freedman, L. Brian, and K. Peppel Graft-Extrinsic Cells Predominate in Vein Graft Arterialization Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 470 - 476. [Abstract] [Full Text]
|
|
|
|
|
|
J. P.G Sluijter, M. B Smeets, E. Velema, G. Pasterkamp, and D. P.V de Kleijn Increased collagen turnover is only partly associated with collagen fiber deposition in the arterial response to injury Cardiovasc Res, January 1, 2004; 61(1): 186 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Chamseddine and F. J. Miller Jr. gp91phox Contributes to NADPH oxidase activity in aortic fibroblasts but not smooth muscle cells Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2284 - H2289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. de Kleijn and G. Pasterkamp Toll-like receptors in cardiovascular diseases Cardiovasc Res, October 15, 2003; 60(1): 58 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C.M Siow, C. M Mallawaarachchi, and P. L Weissberg Migration of adventitial myofibroblasts following vascular balloon injury: insights from in vivo gene transfer to rat carotid arteries Cardiovasc Res, July 1, 2003; 59(1): 212 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B Smeets, J. P.G Sluijter, M. M.P.C Donners, E. Velema, S. Heeneman, G. Pasterkamp, and D. P.V de Kleijn Increased arterial expression of a glycosylated haptoglobin isoform after balloon dilation Cardiovasc Res, June 1, 2003; 58(3): 689 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Jacobson, H. M. Dourron, J. Liu, O. A. Carretero, D. J. Reddy, T. Andrzejewski, and P. J. Pagano Novel NAD(P)H Oxidase Inhibitor Suppresses Angioplasty-Induced Superoxide and Neointimal Hyperplasia of Rat Carotid Artery Circ. Res., April 4, 2003; 92(6): 637 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Nussmeier, M. R. Marino, and W. K. Vaughn Hormone replacement therapy is associated with improved survival in women undergoing coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., December 1, 2002; 124(6): 1225 - 1229. [Abstract] [Full Text]
|
|
|
|
|
|
J. M. Strotmann, J. Bauersachs, D. Fraccarollo, M. Kirchengast, P. A. Schnabel, J. Sykora, G. Ertl, and W. Voelker Trauma induced by nontraumatic coronary devices and its impact on vascular reactivity and morphology Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2356 - H2362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zalewski, Y. Shi, and A. G. Johnson Diverse Origin of Intimal Cells: Smooth Muscle Cells, Myofibroblasts, Fibroblasts, and Beyond? Circ. Res., October 18, 2002; 91(8): 652 - 655. [Full Text] [PDF]
|
|
|
|
|
|
A. Vink, A. H. Schoneveld, J. J. van der Meer, B. J. van Middelaar, J. P.G. Sluijter, M. B. Smeets, P. H.A. Quax, S. K. Lim, C. Borst, G. Pasterkamp, et al. In Vivo Evidence for a Role of Toll-Like Receptor 4 in the Development of Intimal Lesions Circulation, October 8, 2002; 106(15): 1985 - 1990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hu, M. Mayr, B. Metzler, M. Erdel, F. Davison, and Q. Xu Both Donor and Recipient Origins of Smooth Muscle Cells in Vein Graft Atherosclerotic Lesions Circ. Res., October 4, 2002; 91 (7): e13 - e20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Das, E. C. Dempsey, J. T. Reeves, and K. R. Stenmark Selective expansion of fibroblast subpopulations from pulmonary artery adventitia in response to hypoxia Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L976 - L986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Dufourcq, T. Couffinhal, P. Alzieu, D. Daret, C. Moreau, C. Duplaa, and J. Bonnet Vitronectin is up-regulated after vascular injury and vitronectin blockade prevents neointima formation Cardiovasc Res, March 1, 2002; 53(4): 952 - 962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sartore, A. Chiavegato, E. Faggin, R. Franch, M. Puato, S. Ausoni, and P. Pauletto Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling: From Innocent Bystander to Active Participant Circ. Res., December 7, 2001; 89(12): 1111 - 1121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Hay, C. Micko, M. F. Prescott, G. Liau, K. Robinson, and H. De Leon Differential Cell Cycle Progression Patterns of Infiltrating Leukocytes and Resident Cells After Balloon Injury of the Rat Carotid Artery Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 1948 - 1954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. De Leon, J. D. Ollerenshaw, K. K. Griendling, and J. N. Wilcox Adventitial Cells Do Not Contribute to Neointimal Mass After Balloon Angioplasty of the Rat Common Carotid Artery Circulation, October 2, 2001; 104(14): 1591 - 1593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Gonzalez, S. M. Arribas, F. Molero, and M. S. Fernandez-Alfonso Effect of removal of adventitia on vascular smooth muscle contraction and relaxation Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2876 - H2881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Miller Jr Adventitial Fibroblasts : Backstage Journeymen Arterioscler. Thromb. Vasc. Biol., May 1, 2001; 21(5): 722 - 723. [Full Text] [PDF]
|
|
|
|
|
|
Y. Shi, R. Niculescu, D. Wang, S. Patel, K. L. Davenpeck, and A. Zalewski Increased NAD(P)H Oxidase and Reactive Oxygen Species in Coronary Arteries After Balloon Injury Arterioscler. Thromb. Vasc. Biol., May 1, 2001; 21(5): 739 - 745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-P. Stoll, G. D. Hutchins, W. L. Winkle, A. T. Nguyen, D. Hou, C. R. Appledorn, B. Romeike, and K. L. March Liquid-Filled Balloon Brachytherapy Using 68Ga Is Effective and Safe Because of the Short 68-Minute Half-Life : Results of a Feasibility Study in the Porcine Coronary Overstretch Model Circulation, April 3, 2001; 103(13): 1793 - 1798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Davenpeck, C. Marcinkiewicz, D. Wang, R. Niculescu, Y. Shi, J. L. Martin, and A. Zalewski Regional Differences in Integrin Expression : Role of {{alpha}}5{beta}1 in Regulating Smooth Muscle Cell Functions Circ. Res., February 16, 2001; 88(3): 352 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Christen, V. Verin, M.-L. Bochaton-Piallat, Y. Popowski, F. Ramaekers, P. Debruyne, E. Camenzind, G. van Eys, and G. Gabbiani Mechanisms of Neointima Formation and Remodeling in the Porcine Coronary Artery Circulation, February 13, 2001; 103(6): 882 - 888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Wallner, B. G. Sharifi, P. K. Shah, S. Noguchi, H. DeLeon, and J. N. Wilcox Adventitial remodeling after angioplasty is associated with expression of tenascin mRNA by adventitial myofibroblasts J. Am. Coll. Cardiol., February 1, 2001; 37(2): 655 - 661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Pagano NAD(P)H Oxidase: Marker of the Dedifferentiated Neointimal Smooth Muscle Cell? Arterioscler. Thromb. Vasc. Biol., February 1, 2001; 21(2): 175 - 177. [Full Text] [PDF]
|
|
|
|
 |
|
 D M Braganza and M R Bennett New insights into atherosclerotic plaque rupture Postgrad. Med. J., February 1, 2001; 77(904): 94 - 98. [Full Text]
|
|
|
|
|
|
P. H. A. Quax, M. L. M. Lamfers, J. H. P. Lardenoye, J. M. Grimbergen, M. R. de Vries, J. Slomp, M. C. de Ruiter, M. M. Kockx, J. H. Verheijen, and V. W. M. van Hinsbergh Adenoviral Expression of a Urokinase Receptor-Targeted Protease Inhibitor Inhibits Neointima Formation in Murine and Human Blood Vessels Circulation, January 30, 2001; 103(4): 562 - 569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Drouilhet III, F. Southern, D. K. Williams, A. T. Brown, J. Eidt, and M. M. Moursi Increased Intimal Hyperplasia After Carotid Endarterectomy in Spontaneously Hypertensive Rats Vascular and Endovascular Surgery, January 1, 2001; 35(1): 11 - 18. [Abstract] [PDF]
|
|
|
|
|
|
E. Sasaki, Y. Tanahashi, Y. Yamasaki, N. Oda, Y. Nozawa, H. Terakawa, K. Miyoshi, Y. Muranaka, H. Miyake, and N. Matsuura Inhibitory Effect of TAS-301, a New Synthesized Constrictive Remodeling Regulator, on Renarrowing after Balloon Overstretch Injury of Porcine Coronary Artery J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 1043 - 1050. [Abstract] [Full Text]
|
|
|
|
|
|
K. Miyata, H. Shimokawa, T. Kandabashi, T. Higo, K. Morishige, Y. Eto, K. Egashira, K. Kaibuchi, and A. Takeshita Rho-Kinase Is Involved in Macrophage-Mediated Formation of Coronary Vascular Lesions in Pigs In Vivo Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20(11): 2351 - 2358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Rodriguez, E. H. Lambert, M. G. Magno, and J. D. Mannion Contractile smooth muscle cell apoptosis early after saphenous vein grafting Ann. Thorac. Surg., October 1, 2000; 70(4): 1145 - 1152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Li, Y.-F. Chen, S. S. Kelpke, S. Oparil, and J. A. Thompson Estrogen Attenuates Integrin-{beta}3-Dependent Adventitial Fibroblast Migration After Inhibition of Osteopontin Production in Vascular Smooth Muscle Cells Circulation, June 27, 2000; 101(25): 2949 - 2955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Otani, H. Ohmiya, R. Hattori, H. Fujii, H. Ninomiya, M. Kido, H. Kawaguchi, M. Osako, H. Imamura, T. Ohta, et al. Potential role of vacuolar H+-adenosine triphosphatase in neointimal formation in cultured human saphenous vein J. Thorac. Cardiovasc. Surg., May 1, 2000; 119(5): 998 - 1007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Li, S.-J. Chen, S. Oparil, Y.-F. Chen, and J. A. Thompson Direct In Vivo Evidence Demonstrating Neointimal Migration of Adventitial Fibroblasts After Balloon Injury of Rat Carotid Arteries Circulation, March 28, 2000; 101(12): 1362 - 1365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Fishbein, J. Waltenberger, S. Banai, L. Rabinovich, M. Chorny, A. Levitzki, A. Gazit, R. Huber, U. Mayr, S. D. Gertz, et al. Local Delivery of Platelet-Derived Growth Factor Receptor-Specific Tyrphostin Inhibits Neointimal Formation in Rats Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 667 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Overhaus, J. Heckenkamp, S. Kossodo, D. Leszczynski, and G. M. LaMuraglia Photodynamic Therapy Generates a Matrix Barrier to Invasive Vascular Cell Migration Circ. Res., February 18, 2000; 86(3): 334 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Patel, Y. Shi, R. Niculescu, E. H. Chung, J. L. Martin, and A. Zalewski Characteristics of Coronary Smooth Muscle Cells and Adventitial Fibroblasts Circulation, February 8, 2000; 101(5): 524 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-C. Desfaits, J. Raymond, and J. P. Muizelaar Growth Factors Stimulate Neointimal Cells In Vitro and Increase the Thickness of the Neointima Formed at the Neck of Porcine Aneurysms Treated by Embolization • Editorial Comment Stroke, February 1, 2000; 31(2): 498 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. H. Strauss and M. Rabinovitch Adventitial Fibroblasts . Defining a Role in Vessel Wall Remodeling Am. J. Respir. Cell Mol. Biol., January 1, 2000; 22(1): 1 - 3. [Full Text]
|
|
|
|
|
|
E. Faggin, M. Puato, A. Chiavegato, R. Franch, P. Pauletto, and S. Sartore Fish Oil Supplementation Prevents Neointima Formation in Nonhypercholesterolemic Balloon-Injured Rabbit Carotid Artery by Reducing Medial and Adventitial Cell Activation Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 152 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Oparil, S.-J. Chen, Y.-F. Chen, J. N Durand, L. Allen, and J. A Thompson Estrogen attenuates the adventitial contribution to neointima formation in injured rat carotid arteries Cardiovasc Res, December 1, 1999; 44(3): 608 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Li, Y.-F. Chen, G. L. Greene, S. Oparil, and J. A. Thompson Estrogen Inhibits Vascular Smooth Muscle Cell-Dependent Adventitial Fibroblast Migration In Vitro Circulation, October 12, 1999; 100(15): 1639 - 1645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Gutterman Adventitia-dependent influences on vascular function Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1265 - H1272. [Full Text] [PDF]
|
|
|
|
|
|
M. R Dashwood, P. Noertersheuser, M. Kirchengast, and K. Munter Altered endothelin-1 binding following balloon angioplasty of pig coronary arteries: effect of the ETA receptor antagonist, LU 135252 Cardiovasc Res, August 1, 1999; 43(2): 445 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Gyongyosi, P Yang, A Hassan, F Weidinger, H Domanovits, A Laggner, and D Glogar Arterial remodelling of native human coronary arteries in patients with unstable angina pectoris: a prospective intravascular ultrasound study Heart, July 1, 1999; 82(1): 68 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Faggin, M. Puato, L. Zardo, R. Franch, C. Millino, F. Sarinella, P. Pauletto, S. Sartore, and A. Chiavegato Smooth Muscle-Specific SM22 Protein Is Expressed in the Adventitial Cells of Balloon-Injured Rabbit Carotid Artery Arterioscler. Thromb. Vasc. Biol., June 1, 1999; 19(6): 1393 - 1404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shi, S. Patel, R. Niculescu, W. Chung, P. Desrochers, and A. Zalewski Role of Matrix Metalloproteinases and Their Tissue Inhibitors in the Regulation of Coronary Cell Migration Arterioscler. Thromb. Vasc. Biol., May 1, 1999; 19(5): 1150 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Shiota, H. Okunishi, S. Takai, I. Mikoshiba, H. Sakonjo, N. Shibata, and M. Miyazaki Tranilast Suppresses Vascular Chymase Expression and Neointima Formation in Balloon-Injured Dog Carotid Artery Circulation, March 2, 1999; 99(8): 1084 - 1090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C Newby and A. B Zaltsman Fibrous cap formation or destruction -- the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation Cardiovasc Res, February 1, 1999; 41(2): 345 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Tjurmin, N. M. Ananyeva, E. P. Smith, Y. Gao, M. K. Hong, M. B. Leon, and C. C. Haudenschild Studies on the Histogenesis of Myxomatous Tissue of Human Coronary Lesions Arterioscler. Thromb. Vasc. Biol., January 1, 1999; 19(1): 83 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Kwon, G. Sangiorgi, E. L. Ritman, A. Lerman, C. McKenna, R. Virmani, W. D. Edwards, D. R. Holmes, and R. S. Schwartz Adventitial vasa vasorum in balloon-injured coronary arteries: Visualization and quantitation by a microscopic three-dimensional computed tomography technique J. Am. Coll. Cardiol., December 1, 1998; 32(7): 2072 - 2079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. McKenna, S. E. Burke, T. J. Opgenorth, R. J. Padley, L. J. Camrud, A. R. Camrud, J. Johnson, P. J. Carlson, A. Lerman, D. R. Holmes Jr, et al. Selective ETA Receptor Antagonism Reduces Neointimal Hyperplasia in a Porcine Coronary Stent Model Circulation, June 30, 1998; 97(25): 2551 - 2556. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||